Making the undruggable druggable

Unlocking challenging drug targets for the development of next-generation therapeutics

Selected Collaborations

Sanofi
Bayer
MSD
Boehringer
AstraZeneca
GSK

It all starts with the drug target.

The majority of drug targets are so-called membrane proteins, and these are inherently unstable and challenging to investigate. Or so they were, until now.

Our proprietary Salipro® technology stabilizes membrane proteins in their native forms, enabling them to be employed in drug discovery programs for therapeutic antibodies or small molecule drugs. Through our in-house and partnered pipelines, we drive the discovery of novel drugs.

 
 
World+map+gray.jpg

Pushing drug development forward together

We work with top-tier pharma and biotech partners to unlock drug targets for drug development programs.

 

Pipeline

We are driving forward drug development in our partnered as well as internal pipelines.


News

Global Pharma Partner Expands Collaboration with Salipro Biotech

2026-11-18
Salipro Biotech AB today announced the expansion of its ongoing collaboration with a global pharmaceutical company, further strengthening the growing portfolio of partner programs leveraging the Salipro® platform.The expanded activities build on ongoing drug discovery programs focused on challenging membrane protein targets, including GPCRs, ion channels and transporters.

Salipro to PSDI 2026

2026-10-27
Salipro Biotech is participating in PSDI 2026, the 34th Protein Structure Determination in Industry Meeting, taking place in Marstrand, Sweden, on November 8-10.

Our Senior Scientist, Anne-Sophie Åstrand Tournillon, will be there presenting a poster showcasing the latest cryoEM structures enabled with the Salipro® platform to advance membrane protein research and drug discovery.

If you’ll be there, be sure to stop by her poster and connect with her to learn more about membrane protein research or collaboration opportunities.

We look forward to meeting fellow scientists and industry partners at the event!

Find information about the conference: https://www.psdi2026.com/

Salipro Biotech to BIO-Europe 2026

2026-10-20
Salipro Biotech is attending BIO-Europe 2026!

Our Business Development Manager, Lorena Galán Acosta, is attending BIO-Europe, taking place in Cologne (Germany) on November 9-11.

It's always a great opportunity to meet our partners, exchange ideas and explore new collaborations.

If you're attending and would like to learn more about how the Salipro® platform enables access to native stabilized membrane proteins for applications including structural biology, biophysics, screening and drug discovery, we’d be happy to connect.

Feel free to reach out via the partneringONE platform to schedule a meeting.

See you in Cologne!